Medical Devices

Xydex Corporation

Brief Description

Tweezers for dextrous manipulation of micro objects.

Inventors

Ronald Fearing, Eiji Shimada

Timeline 2001. Company founded.

YourChoice Therapeutics

Brief Description

YourChoice Therapeutics is revolutionizing birth control options for women and men by developing hormone-free contraceptives and bringing them to market. Our technology is the result of a decade of research at the University of California, Berkeley and has been published in numerous high-impact journals.

Inventors

Yuriy Kirichok, Polina Lishko, Nadja Mannowetz, Melissa Miller

Company Founders

Nadja Mannowetz, Akash Bakshi

Timeline 2018. Company founded

Xip Diagnostics

Brief Description

Xip Diagnostics develops analytical solutions that advance human and animal health at the point of need through in-house product development and industry-leading collaborations.

The company's disposable blood analyzers wirelessly upload lab-quality clinical measurements in minutes, providing blood testing with no hassles, no delays, and no instrument. These devices will be deployed in Emergency Departments (EDs), clinics, and eventually the home.

Xip Diagnostics Founder and CEO Dr. Octavian Florescu spun out the company to commercialize research discoveries...

Vitruvian Medical Devices

Brief Description

Vitruvian Medical Devices specializes in surgical device innovations and wound care. The company's first product, MYOSEAL, is a sealing spray designed to prevent incisional hernias post operations. The company is working on refining a second product, the Sentinel Bandage - a bandage that senses tissue damage in real-time to prevent the formation of pressure ulcers.

The company has been incubated in the UCSF Catalyst Program, UCSF LaunchPad, QB3 Startup-in-a-Box, and National Science Foundation I-Corps Lean Startup.

Inventors

Ana Claudia Arias, Daniel Cohen,...

Thuris Corporation

Brief Description

Thuris Corporation was a biopharmaceutical company focused on medical device solutions to aid in drug development and diagnosis of central nervous system (CNS) disorders including mild cognitive impairment and Alzheimer's disease. Thuris was also developing pharmaceuticals for select CNS orphan and niche indications ranging from ischemia-related conditions, brain inflammation and Huntington's disease. Thuris received 510k FDA clearance for a non-invasive medical device, the NeuroGraph, for diagnosis of neurological and psychiatric disorders over a broad range of brain-...

Tenaya Therapeutics

Brief Description

Tenaya Therapeutics is shaping the future of heart disease treatment driven by a mission to discover, develop, and deliver curative therapies that address the underlying drivers of heart disease. Tenaya is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three platforms: Gene Therapy, Cellular Regeneration, and Precision Medicine. The company was spun out of a new method for creating three-dimensional human heart tissue from stem cells, developed in a collaboration between UC Berkeley Professor of Materials Science...

RS3Dprints

Brief Description

3D printing for medical and food applications. Mass producing alternative steaks from alternative ground beef. Scalable solution for 3D printed alternative meat.

The Cryolithographic Technology was initially developed to produce biological organs for organ transplant. Realizing that there was an immediate commercial opportunity in food production, RS3Dprints was spun out of the lab.

Inventors

Boris Rubinsky, Ze'ev Shaked, Michal Adamkievicz

Company Founders

Dan Rubinsky

Timeline 2016. Company founded

Organos, Inc.

Brief Description Developer of cardiac micro physiological systems designed to offer three-dimensional (3D) human cardiac tissue models for advanced analysis. The company's data science ecosystem is used to illuminate the effects of compounds on human cardiac tissue, ranging from acute cardiotoxicity and safety pharmacology to chronic studies to predict drug-induced arrhythmia, thereby enabling the health industry to perform safer and cheaper drug development activities. Inventors

Kevin Healy, SoonGweon Hong, Luke Lee, Peter Loskill, Anurag Mathur Pia, Rodriguez Nunez...

OncoRx Pharmaceuticals, Inc.

Brief Description

OncoRx Pharmaceuticals is an early-stage pharmaceutical company discovering and developing targeted therapies that control the progression of invasive malignant cancer. OncoRx has identified and tested drugs that markedly alter the sustained directional mobility, the uncontrolled cell cycle, and t​​he unrestrained growth and proliferation of intrinsically and acquired therapy-resistant tumors. Unlike non-aggressive primary tumors, the growth, progression and invasiveness of therapy-resistant tumors are not effectively controlled with currently available cancer therapies...

Oncobionic

Brief Description

Oncobionic commercialized irreversible electroporation (IRE) technology, a minimally invasive treatment for tumors that revolutionized cancer therapy. The minimally invasive surgical system delivers 1,500 volts of electric current through needle-like probes, ablating the targeted area, making it possible to remove unresectable tumors near critical structures and major blood vessels without cuts or incisions. IRE exclusively targets the tumor’s cell membranes, leaving critical organs, vasculature, ducts and nerves completely unharmed.

The IRE...